Show simple item record

Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices

dc.contributor.authorPatel, Nisarg A.en_US
dc.date.accessioned2017-11-21T20:43:32Z
dc.date.issued2017en_US
dc.identifier.citationPatel, Nisarg A. 2017. “Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices.” Journal of Law and the Biosciences 4 (1): 205-215. doi:10.1093/jlb/lsx002. http://dx.doi.org/10.1093/jlb/lsx002.en
dc.identifier.issnen
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:34375195
dc.description.abstracten
dc.language.isoen_USen
dc.publisherOxford University Pressen
dc.relation.isversionofdoi:10.1093/jlb/lsx002en
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570706/pdf/en
dash.licenseLAAen_US
dc.titleFee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug pricesen
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalJournal of Law and the Biosciencesen
dash.depositing.authorPatel, Nisarg A.en_US
dc.date.available2017-11-21T20:43:32Z
dc.identifier.doi10.1093/jlb/lsx002*
dash.contributor.affiliatedPatel, Nisarg


Files in this item

Thumbnail
Name:
5570706.pdf
Size:
285.2Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record